Ozempic (semaglutide) is a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown significant weight loss effects. Wegovy is the FDA-approved weight-loss formulation of the same medication. We prescribe, titrate, and monitor semaglutide as part of a comprehensive medical weight loss program.
Signs & symptoms
- BMI ≥ 30 (obesity)
- BMI ≥ 27 with weight-related condition (hypertension, diabetes, high cholesterol)
- Failed attempts at sustained weight loss through diet and exercise alone
- Weight-related joint pain, sleep apnea, or fatigue
- Family history of obesity or metabolic syndrome
- Interest in medication-assisted weight loss
Our approach
We start at the lowest dose and titrate up based on tolerability. Nausea is the most common side effect and typically improves over weeks. We monitor for efficacy, side effects, and nutritional adequacy at regular follow-up visits. Adequate protein intake and physical activity are strongly encouraged alongside the medication.
Who is this for?
Adults meeting BMI criteria who are looking for medically supervised weight loss with ongoing provider support.
Start your journey to total wellness today.
No referral needed. Most major insurance plans accepted. Telehealth appointments available across DC and Maryland.